A modified physiologic test for bronchopulmonary dysplasia: A clinical tool for weaning from CPAP and/or oxygen-therapy the premature babies?

Giovanni Vento, Valentina Vendettuoli, Claudia Aurilia, Milena Tana, Chiara Tirone, Alessandra Lio, Piero Giuseppe Matassa, Francesca Priolo, Piero Catenazzi, Mirta Corsello, Enrico Zecca, Fabio Mosca

Research output: Contribution to journalArticle

Abstract

Background: A physiologic test for estimating BPD rate has been developed by Walsh and collaborators. Actually there are not standard criteria for weaning from CPAP and/or oxygen therapy the premature babies. Aim of this study was to verify if a physiologic test, modified respect to that developed by Walsh and collaborators for estimating BPD rate, can be used as a clinical tool for weaning the premature babies from CPAP and/or oxygen therapy. Methods: Neonates with BW 500-1250 g and GA ≤ 32 weeks, receiving FiO 2 ≤ 0.30 by hood or CPAP, were prospectively studied at 28 days of life and at 36 weeks of postmestrual age. The test was performed in 3 steps: baseline, challenge (FiO 2 and CPAP reduction to room air) and post test (room air). Monitoring of transcutaneous CO 2 was added to SpO 2 and the newborns passing the test were left in room air. Results: Six of 23 tested babies (26%) passed the challenge at 28 days of life, 4 of 10 tested babies (40%) passed the challenge at 36 weeks. Median values of SpO 2 were significantly higher in the neonates passing the test, respect to the failing patients. At the same time median values of TcPCO 2 were significantly higher in the latter babies. Conclusion: TcPCO 2 monitoring appeared to be a new useful parameter for failure prediction of weaning. The test represented a clinical guide because the newborns passing it were left in room air.

Original languageEnglish
Article number2
JournalItalian Journal of Pediatrics
Volume45
Issue number1
DOIs
Publication statusPublished - Jan 4 2019

Fingerprint

Bronchopulmonary Dysplasia
Weaning
Air
Newborn Infant
Oxygen
Therapeutics
Carbon Monoxide

Keywords

  • Physiologic test
  • Preterm infants
  • Respiratory support weaning

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

A modified physiologic test for bronchopulmonary dysplasia : A clinical tool for weaning from CPAP and/or oxygen-therapy the premature babies? / Vento, Giovanni; Vendettuoli, Valentina; Aurilia, Claudia; Tana, Milena; Tirone, Chiara; Lio, Alessandra; Matassa, Piero Giuseppe; Priolo, Francesca; Catenazzi, Piero; Corsello, Mirta; Zecca, Enrico; Mosca, Fabio.

In: Italian Journal of Pediatrics, Vol. 45, No. 1, 2, 04.01.2019.

Research output: Contribution to journalArticle

Vento, Giovanni ; Vendettuoli, Valentina ; Aurilia, Claudia ; Tana, Milena ; Tirone, Chiara ; Lio, Alessandra ; Matassa, Piero Giuseppe ; Priolo, Francesca ; Catenazzi, Piero ; Corsello, Mirta ; Zecca, Enrico ; Mosca, Fabio. / A modified physiologic test for bronchopulmonary dysplasia : A clinical tool for weaning from CPAP and/or oxygen-therapy the premature babies?. In: Italian Journal of Pediatrics. 2019 ; Vol. 45, No. 1.
@article{f2efe25dc7e04b70ab2493ef300bdcc2,
title = "A modified physiologic test for bronchopulmonary dysplasia: A clinical tool for weaning from CPAP and/or oxygen-therapy the premature babies?",
abstract = "Background: A physiologic test for estimating BPD rate has been developed by Walsh and collaborators. Actually there are not standard criteria for weaning from CPAP and/or oxygen therapy the premature babies. Aim of this study was to verify if a physiologic test, modified respect to that developed by Walsh and collaborators for estimating BPD rate, can be used as a clinical tool for weaning the premature babies from CPAP and/or oxygen therapy. Methods: Neonates with BW 500-1250 g and GA ≤ 32 weeks, receiving FiO 2 ≤ 0.30 by hood or CPAP, were prospectively studied at 28 days of life and at 36 weeks of postmestrual age. The test was performed in 3 steps: baseline, challenge (FiO 2 and CPAP reduction to room air) and post test (room air). Monitoring of transcutaneous CO 2 was added to SpO 2 and the newborns passing the test were left in room air. Results: Six of 23 tested babies (26{\%}) passed the challenge at 28 days of life, 4 of 10 tested babies (40{\%}) passed the challenge at 36 weeks. Median values of SpO 2 were significantly higher in the neonates passing the test, respect to the failing patients. At the same time median values of TcPCO 2 were significantly higher in the latter babies. Conclusion: TcPCO 2 monitoring appeared to be a new useful parameter for failure prediction of weaning. The test represented a clinical guide because the newborns passing it were left in room air.",
keywords = "Physiologic test, Preterm infants, Respiratory support weaning",
author = "Giovanni Vento and Valentina Vendettuoli and Claudia Aurilia and Milena Tana and Chiara Tirone and Alessandra Lio and Matassa, {Piero Giuseppe} and Francesca Priolo and Piero Catenazzi and Mirta Corsello and Enrico Zecca and Fabio Mosca",
year = "2019",
month = "1",
day = "4",
doi = "10.1186/s13052-018-0582-x",
language = "English",
volume = "45",
journal = "Italian Journal of Pediatrics",
issn = "1720-8424",
publisher = "BioMed Central Ltd.",
number = "1",

}

TY - JOUR

T1 - A modified physiologic test for bronchopulmonary dysplasia

T2 - A clinical tool for weaning from CPAP and/or oxygen-therapy the premature babies?

AU - Vento, Giovanni

AU - Vendettuoli, Valentina

AU - Aurilia, Claudia

AU - Tana, Milena

AU - Tirone, Chiara

AU - Lio, Alessandra

AU - Matassa, Piero Giuseppe

AU - Priolo, Francesca

AU - Catenazzi, Piero

AU - Corsello, Mirta

AU - Zecca, Enrico

AU - Mosca, Fabio

PY - 2019/1/4

Y1 - 2019/1/4

N2 - Background: A physiologic test for estimating BPD rate has been developed by Walsh and collaborators. Actually there are not standard criteria for weaning from CPAP and/or oxygen therapy the premature babies. Aim of this study was to verify if a physiologic test, modified respect to that developed by Walsh and collaborators for estimating BPD rate, can be used as a clinical tool for weaning the premature babies from CPAP and/or oxygen therapy. Methods: Neonates with BW 500-1250 g and GA ≤ 32 weeks, receiving FiO 2 ≤ 0.30 by hood or CPAP, were prospectively studied at 28 days of life and at 36 weeks of postmestrual age. The test was performed in 3 steps: baseline, challenge (FiO 2 and CPAP reduction to room air) and post test (room air). Monitoring of transcutaneous CO 2 was added to SpO 2 and the newborns passing the test were left in room air. Results: Six of 23 tested babies (26%) passed the challenge at 28 days of life, 4 of 10 tested babies (40%) passed the challenge at 36 weeks. Median values of SpO 2 were significantly higher in the neonates passing the test, respect to the failing patients. At the same time median values of TcPCO 2 were significantly higher in the latter babies. Conclusion: TcPCO 2 monitoring appeared to be a new useful parameter for failure prediction of weaning. The test represented a clinical guide because the newborns passing it were left in room air.

AB - Background: A physiologic test for estimating BPD rate has been developed by Walsh and collaborators. Actually there are not standard criteria for weaning from CPAP and/or oxygen therapy the premature babies. Aim of this study was to verify if a physiologic test, modified respect to that developed by Walsh and collaborators for estimating BPD rate, can be used as a clinical tool for weaning the premature babies from CPAP and/or oxygen therapy. Methods: Neonates with BW 500-1250 g and GA ≤ 32 weeks, receiving FiO 2 ≤ 0.30 by hood or CPAP, were prospectively studied at 28 days of life and at 36 weeks of postmestrual age. The test was performed in 3 steps: baseline, challenge (FiO 2 and CPAP reduction to room air) and post test (room air). Monitoring of transcutaneous CO 2 was added to SpO 2 and the newborns passing the test were left in room air. Results: Six of 23 tested babies (26%) passed the challenge at 28 days of life, 4 of 10 tested babies (40%) passed the challenge at 36 weeks. Median values of SpO 2 were significantly higher in the neonates passing the test, respect to the failing patients. At the same time median values of TcPCO 2 were significantly higher in the latter babies. Conclusion: TcPCO 2 monitoring appeared to be a new useful parameter for failure prediction of weaning. The test represented a clinical guide because the newborns passing it were left in room air.

KW - Physiologic test

KW - Preterm infants

KW - Respiratory support weaning

UR - http://www.scopus.com/inward/record.url?scp=85059497286&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059497286&partnerID=8YFLogxK

U2 - 10.1186/s13052-018-0582-x

DO - 10.1186/s13052-018-0582-x

M3 - Article

C2 - 30609929

AN - SCOPUS:85059497286

VL - 45

JO - Italian Journal of Pediatrics

JF - Italian Journal of Pediatrics

SN - 1720-8424

IS - 1

M1 - 2

ER -